Repligen Corp (NASDAQ:RGEN)

30.57
Delayed Data
As of Mar 27
 +2.00 / +7.00%
Today’s Change
12.04
Today|||52-Week Range
34.15
+54.39%
Year-to-Date

Today’s Trading

Previous close28.57
Today’s open28.60
Day’s range28.29 - 30.82
Volume326,720
Average volume (3 months)387,603
Market cap$1.0B
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)+14.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-6.78%
P/E ratio124.5
Price/Sales10.13
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ZSPHZS Pharma Inc+0.03+0.07%
INSMInsmed Inc+1.03+5.29%
TXMDTherapeuticsMD Inc+0.18+3.09%
ARRYArray Biopharma Inc+0.07+0.95%
Data as of 4:01pm ET, 03/27/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)$0.07
Annual revenue (last year)$63.5M
Annual profit (last year)$8.2M
Net profit margin12.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Treasurer, Director &
CAO
Walter C. Herlihy
Chief Operating Officer &
Director
Tony J. Hunt
Corporate headquarters
Waltham, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account